# Commission Regulation (EU) No 544/2011 of 10 June 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the data requirements for active substances (Text with EEA relevance) (repealed), Division 5.1.1: Medical data

Extent: E+W+S+N.I.

Where available, and without prejudice to the provisions of the EU-derived domestic legislation which transposed Article 10 of Directive 98/24/EC, practical data and information relevant to the recognition of the symptoms of infection or pathogenicity and on the effectiveness of first aid and therapeutic measures have to be submitted. Where relevant, the effectiveness of potential antagonists, shall be investigated and reported. Where relevant, methods to kill or render the micro-organism uninfective must be indicated (see point 3.8).
Data and information relevant to the effects of human exposure, where available and of the necessary quality, are of particular value, in confirming the validity of extrapolations made and conclusions reached with respect to target organs, virulence, and the reversibility of adverse effects. Such data can be generated following accidental or occupational exposure.

---
Source: https://www.legislation.gov.uk/eur/2011/544/annex/part/B/division/5/division/2/division/5.1/division/5.1.1 (the official version)
Page: https://openlegislation.uk/eu-regulation-2011-544/annex/part-B/division-5/division-2/division-5.1/division-5.1.1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

